Publications

Year of Publicationsort ascending Title Faculty Association
2023 The Drinking Water and Swimming Pool Disinfectant Trichloroisocyanuric Acid Causes Chlorination Stress Enhancing Solar UV-Induced Inflammatory Gene Expression in AP-1 Transgenic SKH-1 Luciferase Reporter Mouse Skin. Sally Dickinson, Ph.D.
2023 Chronic pain recruits hypothalamic dynorphin/kappa opioid receptor signalling to promote wakefulness and vigilance. Edita Navratilova, Frank Porreca, PhD
2023 Medication overuse headache. Frank Porreca, PhD
2023 Development and evaluation of a pre-clerkship spiral curriculum: data from three medical school classes. Todd Vanderah, PhD
2023 Green Light Exposure Elicits Anti-inflammation, Endogenous Opioid Release and Dampens Synaptic Potentiation to Relieve Post-surgical Pain. Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD
2023 Loss of fatty acid degradation by astrocytic mitochondria triggers neuroinflammation and neurodegeneration. Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D.
2023 The natural product argentatin C attenuates postoperative pain via inhibition of voltage-gated sodium and T-type voltage-gated calcium channels. John M. Streicher, PhD
2023 Investigation of the impact of bacterial microencapsulation on natural product discovery Christopher Cartmell
2022 Blood-Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke. Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS
2022 Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies. Mohab M. Ibrahim, PhD, MD, Laurent F Martin
2022 Cerebral arteriolar and neurovascular dysfunction after chemically induced menopause in mice. Tally Largent-Milnes, PhD
2022 Effects of docosahexaenoic acid and eicosapentaoic acid supplementation on white matter integrity after repetitive sub-concussive head impacts during American football: Exploratory neuroimaging findings from a pilot RCT. Roberta Diaz Brinton, Ph.D
2022 EPDR1 is a noncanonical effector of insulin-mediated angiogenesis regulated by an endothelial-specific TGF-β receptor complex. Nam Lee, Ph.D.
2022 Targeting organic cation transporters at the blood-brain barrier to treat ischemic stroke in rats. Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS
2022 Design, Physicochemical Characterization, and In Vitro Permeation of Innovative Resatorvid Topical Formulations for Targeted Skin Drug Delivery. Sally Dickinson, Ph.D.
2022 High-Dose Acetaminophen Alters the Integrity of the Blood-Brain Barrier and Leads to Increased CNS Uptake of Codeine in Rats. Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS
2022 Targeting 5-HT receptors and Kv7 channels in PFC to attenuate chronic neuropathic pain in rats using a spared nerve injury model. Tally Largent-Milnes, PhD, Arthur Charles Riegel, Todd Vanderah, PhD
2022 Kappa Opioid Receptor Blockade in the Amygdala Mitigates Pain Like-Behaviors by Inhibiting Corticotropin Releasing Factor Neurons in a Rat Model of Functional Pain. Edita Navratilova, Frank Porreca, PhD
2022 Synthesis of ()()-Tiruchanduramine. Christopher Cartmell
2022 Contributions of sex and genotype to exploratory behavior differences in an aged humanized mouse model of late-onset Alzheimer's disease. Roberta Diaz Brinton, Ph.D
2022 Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer. Nam Lee, Ph.D.
2022 Age-Induced Changes in μ-Opioid Receptor Signaling in the Midbrain Periaqueductal Gray of Male and Female Rats. John M. Streicher, PhD
2022 Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-/Activin Receptor-Like Kinase 1 Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (i.e., Statins). Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS
2022 Microencapsulation and incubation methodology for the cultivation of marine bacteria. Christopher Cartmell
2022 Androgen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer. Roberta Diaz Brinton, Ph.D, Kathleen Rodgers, Ph.D.

Pages